Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nova Eye Medical ( (AU:EYE) ) has shared an announcement.
Nova Eye Medical Limited has applied for quotation on the ASX of 28,000 additional ordinary fully paid shares, to be issued on 8 May 2026. The new securities arise from an employee incentive scheme and their quotation will modestly increase the company’s free float, aligning staff incentives with shareholder interests without materially diluting existing holders.
More about Nova Eye Medical
Nova Eye Medical Limited is an Australia-listed ophthalmic company focused on eye care technologies. The company’s ordinary shares trade on the ASX under the ticker EYE, reflecting its positioning within the medical and healthcare segment of the equity market.
Average Trading Volume: 264,783
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$35.61M
For a thorough assessment of EYE stock, go to TipRanks’ Stock Analysis page.